Current Edition

The Expanding Role of MRI in the Pharmaceutical Industry

With ever-increasing pressure on drug development pipelines and a growing need to demonstrate convincing mechanisms of action as a part of the registration process for new drugs, innovative methods are being sought that can streamline the traditional drug development process. Matt Wall of Imanova proves that imaging methods have a substantial potential to impact the development and clinical trials process at several stages, and have begun to be used as a method of bolstering the uptake and marketing of already-marketed compounds.